Cura Sen Therapeutics Appoints Kathleen Sereda Glaub As CEO and Dr. Anthony Ford As President and CSO
Cura Sen Therapeutics Appoints Kathleen Sereda Glaub As CEO and Dr. Anthony Ford As President and CSO
10/15/24, 1:26 PM
Location
san carlosIndustry
biotechnology
Position
chief executive officer
CuraSen Therapeutics, Inc has appointed Kathleen Sereda Glaub as chief executive officer and Dr Anthony Ford as president and chief scientific officer. Along with these changes, the company announced clinical program updates for its drug candidates designed to restore adrenergic stimulus that declines with age or disease.
Company Info
Location
733 industrial road
san carlos, california, united states
Additional Info
CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications. Millions of patients and their families are burdened by these diseases, and the numbers continue to grow annually with the aging population.